GSIW
Garden Stage Limited Ordinary Shares
NASDAQ · Financial Services · Financial - Capital Markets · KY
$16.50
−3.85%Income statement
| Metric | TTM | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 12.7M | 7.3M | 5.4M | 1.4M | 415.8K |
| Cost of Revenue | 11.5M | 6.5M | 5.1M | 3.4M | 35.7K |
| Gross Profit | 1.2M | 731.6K | 255.3K | (2.0M) | 380.1K |
| Operating Expenses | |||||
| R&D Expense | — | — | — | — | — |
| SG&A Expense | 461.7K | — | 4.4M | 2.6M | 1.2M |
| General & Admin Expense | — | — | 2.9M | 1.0M | 916.1K |
| Selling & Marketing Expense | — | — | 1.5M | 1.6M | 236.1K |
| Other Expenses | 22.4M | 14.6M | 156.8K | 17.1K | 2.8K |
| Total Operating Expenses | 19.4M | 14.6M | 4.6M | 2.6M | 1.1M |
| Cost and Expenses | 27.4M | 21.1M | 9.7M | 6.0M | 442.3K |
| Operating Income (EBIT) | (18.2M) | (13.9M) | (4.3M) | (4.6M) | (26.5K) |
| Non-Operating | |||||
| Interest Income | 750.1K | 750.1K | 58.1K | 38.7K | 47.8K |
| Interest Expense | — | — | — | — | — |
| Net Interest Income | 750.1K | 750.1K | 58.1K | 38.7K | 47.8K |
| Other Non-Op Income/Expense | (2.0K) | — | 48.0K | — | 181.2K |
| Non-Operating Income (excl Interest) | — | — | — | 43.9K | 50.7K |
| EBT (Pre-Tax Income) | (15.3M) | (13.9M) | (4.3M) | (4.6M) | (26.5K) |
| Income Tax Expense | 25.0K | (22.8K) | 43.2K | 13.4K | (66.85) |
| Bottom Line | |||||
| Net Income | (15.3M) | (13.8M) | (4.3M) | (4.6M) | (26.4K) |
| Earnings from Cont. Ops | (15.3M) | (13.8M) | (4.3M) | (4.6M) | (26.4K) |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (15.3M) | (13.8M) | (4.3M) | (4.6M) | (207.2K) |
| Per Share | |||||
| Basic EPS | ($0.73) | ($1.38) | ($0.02) | ($0.02) | ($0.00) |
| Diluted EPS | ($0.73) | ($1.38) | ($0.02) | ($0.02) | ($0.00) |
| Revenue Per Share | $1.18 | $0.73 | $0.02 | $0.01 | $0.00 |
| Shares | |||||
| Basic Shares Outstanding | 10.7M | 10.0M | 218.8M | 190.6M | 213.5M |
| Diluted Shares Outstanding | 10.7M | 10.0M | 218.8M | 190.6M | 213.5M |
| Profitability Metrics | |||||
| EBITDA | (16.9M) | (12.6M) | (4.2M) | (4.5M) | (16.4K) |
| D&A | 1.3M | 1.2M | 165.7K | 82.2K | 10.1K |
| EBIT | (18.2M) | (13.9M) | (4.3M) | (4.6M) | (258.3K) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026